Clinical Trial Update: Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the efficacy and tolerability of weekly doxorubicin in elderly patients with advanced or metastatic leiomyosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Sarcoma | Phase 2 | Status: RECRUITING